The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 16th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
FDA Requires Manufacturers to Investigate Infection Risk Associated with Duodenoscope Use
The US Food and Drug Administration requested three manufacturers of duodenoscopes – Olympus America, Inc. Fujifilm Medical Systems, USA, Inc., and Hoya Corp – to perform real-world postmarket surveillance studies duodenoscopes used to perform endoscopic retrograde cholangiopancreatography procedures (ERCP).
Study: "Obesity Paradox" in Cardiovascular Disease Does Not Exist
The "obesity paradox" suggests that patients with excess weight are associated with better survival among individuals with cardiovascular disease -a mysterious and confounding phenomenon that has been demonstrated in many clinical studies.
Treating Patients with Resistance to Thyroid Hormone
October 1st 2015Resistance to thyroid hormone (RTH) occurs in rare patients and its clinical presentation is considerably different than that seen in the usual hyperthyroid patient. Patients with this inherited condition produce inordinate levels of thyroid hormone because their negative feedback loop at the pituitary gland is metaphorically snipped. Concurrently, they have normal levels of thyroid-stimulating hormone.
Hospital Uses Established Tools to Reduce Diabetes Medication Errors
September 29th 2015An article published in Clinical Interventions in Aging outlined a large hospital's successful quality improvement interventions over 5 years to reduce medication errors in their large population of diabetic patients.
Drop That Big Mac and Check Out This One-Hour Timeline of Unhealthy Effects
September 24th 2015Devoted soda drinkers began to lose their minds when an infographic outlining the harmful effects a single can of Coca-Cola has on the body in one hour began circulating the Internet. Now a new infographic has revealed what a Big Mac from McDonald's can do to the body in the same amount of time.
Soda, Pop, Coke: Who Drinks What and Where?
September 21st 2015In an effort to fight obesity and diabetes and promote healthier diet and lifestyle choices through targeted interventions, public health officials determined which regions of the US have the highest levels of soda and other sugar-sweetened beverage consumption.
Massive Weight Loss Patients Appear Significantly Older than They Are Prior to Facial Surgery
Massive weight loss (MWL) provides obvious health benefits, including reducing morbidity and mortality risks, but it brings some medical and psychological challenges as well. MWL patients are often left with excessive amounts of sagging skin, particularly in the thighs, under the arms, around the abdomen, and around the face.
Precision Medicine Applications in Hypogonadism and Other Areas of Men's Health
September 10th 2015Precision medicine's role in the management of hypogonadism is still in its formative stages. Researchers suggest that identifying biomarkers associated with individual patients' treatment responses is possible.
My Weight Loss Avatar: A Buddy that Motivates
September 10th 2015Researchers from the University of Washington in Seattle reported that the use of avatars (digital representations of a coach, buddy, or teacher) improved user satisfaction in interactive, online weight management programs for obese teens.
Pancreatectomy Linked to Endocrine Function Impairment and Diabetes in Women
New research into distal pancreatectomies indicates that women and overweight patients have an elevated risk of suffering endocrine function impairment that leads to glucose intolerance and diabetes mellitus.
Heart Failure, Diabetes, and Medication: An Interesting Triad
September 9th 2015A study published in Metabolic Syndrome and Related Disorders indicates that sodium glucose cotransporter-2 inhibitors (SGLT2 inhibitors, which affect both supply and demand pathways in the heart) may be the preferred treatment for diabetics with heart failure.
Predicting Type 2 Diabetes: Birth Weight as a Surrogate
September 9th 2015Fetal exposure to severe starvation or stress appears to elevate risk of hyperglycemia or type 2 diabetes (T2D) later in life. Similarly, low birth weight has been associated with glucose intolerance, suppressed insulin secretory capacity, and increased risk of T2D.